Emerging Mechanisms of Fluoroquinolone Resistance
Top Cited Papers
Open Access
- 1 March 2001
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 7 (2) , 337-341
- https://doi.org/10.3201/eid0702.010239
Abstract
Volume 7, Number 2—April 2001 - Emerging Infectious Disease journal - CDCKeywords
This publication has 41 references indexed in Scilit:
- Engineering the Specificity of Antibacterial Fluoroquinolones: Benzenesulfonamide Modifications at C-7 of Ciprofloxacin Change Its Primary Target in Streptococcus pneumoniae from Topoisomerase IV to GyraseAntimicrobial Agents and Chemotherapy, 2000
- New Uses for New and Old Quinolones and the Challenge of ResistanceClinical Infectious Diseases, 2000
- Streptococcus pneumoniae DNA Gyrase and Topoisomerase IV: Overexpression, Purification, and Differential Inhibition by FluoroquinolonesAntimicrobial Agents and Chemotherapy, 1999
- Type II DNA topoisomerasesCurrent Opinion in Structural Biology, 1998
- Mechanisms of multidrug transportersFEMS Microbiology Reviews, 1997
- Antimicrobial Resistance inNeisseria gonorrhoeaein the United States, 1988–1994: The Emergence of Decreased Susceptibility to the FluoroquinolonesThe Journal of Infectious Diseases, 1997
- Structure and mechanism of DNA topoisomerase IINature, 1996
- The Complex of DNA Gyrase and Quinolone Drugs with DNA Forms a Barrier to Transcription by RNA PolymeraseJournal of Molecular Biology, 1994
- Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examplesAntimicrobial Agents and Chemotherapy, 1993
- Spread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of TypesThe Journal of Infectious Diseases, 1975